Rosemary Hottinger, Clinical Site Coordinator and CER
CHUV CRS, Lausanne, Switzerland
In 1995, with a degree in biochemistry in my pocket from Trinity College Dublin, I jumped at the opportunity to spread my wings and took up a position in pre-clinical research in one of the ‘big-pharma’ in Switzerland. I quickly realized that (a) there is more to Switzerland than chocolate, watches, and mountains, and (b) life in the lab really was not for me. Soon after I found my first position in clinical operations and can truly say that I found my niche. My first encounter with HIV was circa 1997 when I started working on numerous clinical trials many of which ultimately gave rise to some of the antiretroviral therapies in use today. Following a period working mainly on oncology trials for a bio-pharmaceutical company, I decided a change was in order and in April 2018, I had the opportunity to come to work at the university hospital in Lausanne (CHUV) and take up the position of Study Manager at the Vaccine and Immunotherapy Center. This was my first experience working with the HVTN. In terms of HVTN studies, my role is Clinical Site Coordinator and also the Community Educator-Recruiter. Being a relatively recent addition to the Lausanne site, I am progressively getting to know the CAB and gaining a better understanding of my role vis-à-vis the community. The Lausanne CAB is composed of individuals with diverse backgrounds, all deeply committed to the prevention of HIV and who have been instrumental in educating me on the current culture and public opinion in Switzerland and the challenges we face.
From a clinical operations perspective, working with the HVTN, I cannot help but be impressed by the commitment to quality and excellence; all the systems, processes and procedures have been shaped and guided by GCP and every operational aspect of a protocol has a corresponding well thought through practical application.